Involvement of ERK1/2 pathway in BPC-157-induced cell proliferation, migration, and tube formation To explore whether the ERK1/2, JNK, or p38 pathway was involved in BPC-157-induced cell proliferation, migration, and tube formation, PD98059 (ERK1/2 inhibitor), SP600125 (JNK inhibitor), and SB203580 (p38 inhibitor) were used
BPC-157s promotion of vascular growth could enhance supply of nutrients and growth factors to healing tissues, while IGF1 LR3s direct anabolic effects could promote cellular proliferation and protein synthesis in those tissues
All volunteers showed IgM and IgG1 seroconversion and worm-specific cytokine production by CD4+ T cells
Final thoughts Combining cagrilintide with tirzepatide represents an experimental approach with theoretical weight loss potential of 20-30% but zero clinical data supporting safety or efficacy
Gastrointestinal discomfort Occasionally, mild bloating or nausea may occur